Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole

ClinicalTrials.gov ID: NCT01429441

Public ClinicalTrials.gov record NCT01429441. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 12:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Sham-controlled, Double-masked, Multicenter Study Evaluating Ocriplasmin Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the treatment of symptomatic vitreomacular adhesion / (VMT) including macular hole with ocriplasmin.

Study identification

NCT ID
NCT01429441
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
ThromboGenics
Industry
Enrollment
220 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2011 (Type not available)
Primary completion
Oct 2014 (Actual)
Completion
Oct 2014 (Actual)
Last update posted
Mar 14, 2016

2011 – 2014

United States locations

U.S. sites
25
U.S. states
12
U.S. cities
25
Facility City State ZIP Site status
Retinal Consultants of Arizona Phoenix Arizona 85014 —
Retina-Vitreous Associates Medical Group Beverly Hills California 90211 —
Retina Consultants Medical Group Sacramento California 95819 —
West Coast Retina Group, Inc San Francisco California 94107 —
Bay Area Retina Associates Walnut Creek California 94598 —
MedEye Associates Miami Florida 33143 —
Center for Retina and Macular Disease Winter Haven Florida 33880 —
Associated Retinal Consultants Royal Oak Michigan 48073 —
Sabates Eye Center Research Kansas City Missouri 64108 —
Eyesite Opthalmic Services, PA Portsmouth New Hampshire 03801 —
Retina-Vitreous Center, PA New Brunswick New Jersey 08901 —
Retina Association of NJ Teaneck New Jersey 07666 —
Retina Vitrous Surgeons of CNY Syracuse New York 13224 —
Southeast Clinical Research, PA Charlotte North Carolina 28210 —
Cincinnati Eye Institute Cincinnati Ohio 45242 —
Retina Associates of Cleveland Cleveland Ohio 44130 —
Mid Atlantic Retina Huntingdon Valley Pennsylvania 19006 —
Texas Retina Associates Arlington Texas 76012 —
Retina Research Center Austin Texas 78705 —
Texas Retina Associates Dallas Texas 75231 —
Retina Consultants, PA Fort Worth Texas 76104 —
Vitroretinal Consultants Houston Texas 77030 —
Valley Retina Institute, P.A. McAllen Texas 78503 —
Retina Consultants of San Antonio San Antonio Texas 78240 —
Eye Care Associate Tyler Texas 75701 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01429441, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 14, 2016 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01429441 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →